Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Replimune Group, Inc. (REPL) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Replimune Group, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1737953.
Total stock buying since 2018: $33,565,200.
Total stock sales since 2018: $81,905,875.
Total stock option exercises since 2018: $2,296,114.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 84,061 | $652,808 | 0 | $0 |
| 2024 | 0 | $0 | 107,428 | $857,745 | 0 | $0 |
| 2023 | 0 | $0 | 159,192 | $3,006,816 | 45,658 | $386,131 |
| 2022 | 0 | $0 | 166,296 | $2,681,601 | 31,500 | $176,520 |
| 2021 | 0 | $0 | 801,959 | $29,719,960 | 122,000 | $753,968 |
| 2020 | 0 | $0 | 1,069,096 | $39,880,846 | 154,494 | $590,649 |
| 2019 | 1,320,000 | $17,965,200 | 300,000 | $5,106,099 | 83,767 | $236,596 |
| 2018 | 1,040,000 | $15,600,000 | 0 | $0 | 87,000 | $152,250 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 9,154 | $49,156 | 0 | $0 |
| 2025-05 | 0 | $0 | 74,907 | $603,652 | 0 | $0 |
| 2024-12 | 0 | $0 | 10,000 | $124,200 | 0 | $0 |
| 2024-11 | 0 | $0 | 12,453 | $134,242 | 0 | $0 |
| 2024-08 | 0 | $0 | 8,938 | $90,988 | 0 | $0 |
| 2024-06 | 0 | $0 | 15,881 | $119,107 | 0 | $0 |
| 2024-05 | 0 | $0 | 60,156 | $389,208 | 0 | $0 |
| 2023-11 | 0 | $0 | 12,568 | $137,241 | 0 | $0 |
| 2023-09 | 0 | $0 | 5,658 | $113,213 | 5,658 | $18,671 |
| 2023-08 | 0 | $0 | 20,000 | $400,186 | 20,000 | $179,460 |
| 2023-07 | 0 | $0 | 20,000 | $427,500 | 20,000 | $188,000 |
| 2023-06 | 0 | $0 | 18,558 | $441,215 | 0 | $0 |
| 2023-05 | 0 | $0 | 82,408 | $1,487,461 | 0 | $0 |
| 2022-12 | 0 | $0 | 15,000 | $375,450 | 15,000 | $15,150 |
| 2022-05 | 0 | $0 | 44,796 | $653,571 | 0 | $0 |
| 2022-03 | 0 | $0 | 106,500 | $1,652,580 | 16,500 | $161,370 |
| 2021-11 | 0 | $0 | 137,882 | $4,682,212 | 0 | $0 |
| 2021-10 | 0 | $0 | 30,000 | $907,368 | 0 | $0 |
| 2021-09 | 0 | $0 | 142,171 | $4,670,976 | 0 | $0 |
| 2021-08 | 0 | $0 | 60,000 | $1,941,372 | 30,000 | $465,000 |
| 2021-07 | 0 | $0 | 59,810 | $2,003,388 | 22,000 | $22,219 |
| 2021-04 | 0 | $0 | 30,000 | $910,050 | 0 | $0 |
| 2021-03 | 0 | $0 | 30,000 | $999,510 | 0 | $0 |
| 2021-02 | 0 | $0 | 35,249 | $1,322,955 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-15 | Hill Emily Luisa (Chief Financial Officer) | Sale | 9,154 | 5.37 | 49,156 |
| 2025-05-20 | Sarchi Christopher (Chief Commercial Officer) | Sale | 3,749 | 8.05 | 30,179 |
| 2025-05-20 | Schwendenman Andrew (Chief Accounting Officer) | Sale | 3,287 | 8.05 | 26,460 |
| 2025-05-20 | Xynos Konstantinos (Chief Medical Officer) | Sale | 7,952 | 8.06 | 64,093 |
| 2025-05-20 | Patel Sushil (Chief Executive Officer) | Sale | 25,105 | 8.06 | 202,346 |
| 2025-05-20 | Hill Emily Luisa (Chief Financial Officer) | Sale | 2,535 | 8.05 | 20,406 |
| 2025-05-20 | Astley-sparke Philip | Sale | 32,279 | 8.06 | 260,168 |
| 2024-12-16 | Patel Sushil (Chief Executive Officer) | Sale | 10,000 | 12.42 | 124,200 |
| 2024-11-18 | Sarchi Christopher (Chief Commercial Officer) | Sale | 5,207 | 10.78 | 56,131 |
| 2024-11-18 | Xynos Konstantinos (Chief Medical Officer) | Sale | 7,246 | 10.78 | 78,111 |
| 2024-08-16 | Hill Emily Luisa (Chief Financial Officer) | Sale | 8,938 | 10.18 | 90,988 |
| 2024-06-07 | Xynos Konstantinos (Chief Medical Officer) | Sale | 15,881 | 7.50 | 119,107 |
| 2024-05-16 | Sarchi Christopher (Chief Commercial Officer) | Sale | 2,218 | 6.47 | 14,350 |
| 2024-05-16 | Schwendenman Andrew (Chief Accounting Officer) | Sale | 2,298 | 6.47 | 14,868 |
| 2024-05-16 | Xynos Konstantinos (Chief Medical Officer) | Sale | 6,367 | 6.47 | 41,194 |
| 2024-05-16 | Patel Sushil (Chief Executive Officer) | Sale | 20,194 | 6.47 | 130,655 |
| 2024-05-16 | Love Colin (Chief Operating Officer) | Sale | 17,615 | 6.47 | 113,969 |
| 2024-05-16 | Coffin Robert | Sale | 11,464 | 6.47 | 74,172 |
| 2023-11-16 | Sarchi Christopher (Chief Commercial Officer) | Sale | 5,255 | 10.92 | 57,384 |
| 2023-11-16 | Xynos Konstantinos (Chief Medical Officer) | Sale | 7,313 | 10.92 | 79,857 |
| 2023-09-12 | Esposito Pamela (Chief Business Officer) | Sale | 300 | 20.00 | 6,000 |
| 2023-09-12 | Esposito Pamela (Chief Business Officer) | Option Ex | 300 | 3.30 | 990 |
| 2023-09-11 | Esposito Pamela (Chief Business Officer) | Sale | 5,358 | 20.01 | 107,213 |
| 2023-09-11 | Esposito Pamela (Chief Business Officer) | Option Ex | 5,358 | 3.30 | 17,681 |
| 2023-08-22 | Esposito Pamela (Chief Business Officer) | Sale | 18,600 | 20.01 | 372,186 |
| 2023-08-22 | Esposito Pamela (Chief Business Officer) | Option Ex | 18,600 | 9.40 | 174,840 |
| 2023-08-11 | Esposito Pamela (Chief Business Officer) | Sale | 1,400 | 20.00 | 28,000 |
| 2023-08-11 | Esposito Pamela (Chief Business Officer) | Option Ex | 1,400 | 3.30 | 4,620 |
| 2023-07-10 | Esposito Pamela (Chief Business Officer) | Sale | 20,000 | 21.38 | 427,500 |
| 2023-07-10 | Esposito Pamela (Chief Business Officer) | Option Ex | 20,000 | 9.40 | 188,000 |
| 2023-06-13 | Patel Sushil (Chief Strategy Officer) | Sale | 5,698 | 23.77 | 135,469 |
| 2023-06-13 | Lewis Tanya (Chief Dev. Op. Officer) | Sale | 12,860 | 23.77 | 305,746 |
| 2023-05-16 | Xynos Konstantinos (Chief Medical Officer) | Sale | 771 | 18.05 | 13,916 |
| 2023-05-16 | Patel Sushil (Chief Strategy Officer) | Sale | 15,575 | 18.05 | 281,128 |
| 2023-05-16 | Esposito Pamela (Chief Business Officer) | Sale | 5,966 | 18.05 | 107,686 |
| 2023-05-16 | Franchi Jean M. (Chief Financial Officer) | Sale | 11,351 | 18.05 | 204,885 |
| 2023-05-16 | Lewis Tanya (Chief Dev. Op. Officer) | Sale | 12,207 | 18.05 | 220,336 |
| 2023-05-16 | Love Colin (Chief Operating Officer) | Sale | 10,775 | 18.05 | 194,488 |
| 2023-05-16 | Coffin Robert (President & Chief R&D Officer) | Sale | 7,861 | 18.05 | 141,891 |
| 2023-05-16 | Astley-sparke Philip (Chief Executive Officer) | Sale | 17,902 | 18.05 | 323,131 |
| 2022-12-09 | Esposito Pamela (Chief Business Officer) | Sale | 15,000 | 25.03 | 375,450 |
| 2022-12-09 | Esposito Pamela (Chief Business Officer) | Option Ex | 15,000 | 1.01 | 15,150 |
| 2022-05-16 | Patel Sushil (Chief Commercial Officer) | Sale | 10,687 | 14.59 | 155,923 |
| 2022-05-16 | Esposito Pamela (Chief Business Officer) | Sale | 3,507 | 14.59 | 51,167 |
| 2022-05-16 | Franchi Jean M. (Chief Financial Officer) | Sale | 3,436 | 14.59 | 50,131 |
| 2022-05-16 | Lewis Tanya (Chief Dev. Op Officer) | Sale | 5,473 | 14.59 | 79,851 |
| 2022-05-16 | Love Colin (Chief Operating Officer) | Sale | 6,324 | 14.59 | 92,267 |
| 2022-05-16 | Coffin Robert (President & Chief R&D Officer) | Sale | 5,737 | 14.59 | 83,702 |
| 2022-05-16 | Astley-sparke Philip (Chief Executive Officer) | Sale | 9,632 | 14.59 | 140,530 |
| 2022-03-16 | Stampacchia Otello (10% Owner) | Sale | 45,000 | 15.43 | 694,350 |
| 2022-03-15 | Stampacchia Otello (10% Owner) | Sale | 45,000 | 15.64 | 703,800 |
| 2022-03-14 | Stampacchia Otello (10% Owner) | Sale | 16,500 | 15.42 | 254,430 |
| 2022-03-14 | Stampacchia Otello (10% Owner) | Option Ex | 16,500 | 9.78 | 161,370 |
| 2021-11-22 | Stampacchia Otello (Director) | Sale | 10,162 | 34.70 | 352,621 |
| 2021-11-19 | Stampacchia Otello (Director) | Sale | 35,262 | 34.67 | 1,222,533 |
| 2021-11-18 | Stampacchia Otello (Director) | Sale | 4,882 | 33.50 | 163,546 |
| 2021-11-16 | Stampacchia Otello (Director) | Sale | 306 | 33.50 | 10,250 |
| 2021-11-15 | Stampacchia Otello (Director) | Sale | 782 | 33.66 | 26,322 |
| 2021-11-12 | Stampacchia Otello (Director) | Sale | 23,235 | 33.66 | 782,090 |
| 2021-11-11 | Stampacchia Otello (Director) | Sale | 18,279 | 33.61 | 614,357 |
| 2021-11-10 | Stampacchia Otello (Director) | Sale | 11 | 33.50 | 368 |
| 2021-11-09 | Stampacchia Otello (Director) | Sale | 7,537 | 33.73 | 254,223 |
| 2021-11-08 | Stampacchia Otello (Director) | Sale | 3,817 | 33.53 | 127,984 |
| 2021-11-05 | Stampacchia Otello (Director) | Sale | 5,790 | 33.50 | 193,965 |
| 2021-11-04 | Stampacchia Otello (Director) | Sale | 25,225 | 33.58 | 847,055 |
| 2021-10-18 | Love Colin (Chief Operating Officer) | Sale | 12,711 | 29.58 | 375,991 |
| 2021-10-15 | Love Colin (Chief Operating Officer) | Sale | 17,289 | 30.73 | 531,377 |
| 2021-09-23 | Stampacchia Otello (Director) | Sale | 12,171 | 33.58 | 408,702 |
| 2021-09-17 | Stampacchia Otello (Director) | Sale | 94,463 | 33.30 | 3,145,145 |
| 2021-09-16 | Stampacchia Otello (Director) | Sale | 5,537 | 32.55 | 180,229 |
| 2021-09-15 | Love Colin (Chief Operating Officer) | Sale | 30,000 | 31.23 | 936,900 |
| 2021-08-16 | Love Colin (Chief Operating Officer) | Sale | 30,000 | 29.64 | 889,050 |
| 2021-08-05 | Esposito Pamela (Chief Business Officer) | Sale | 25,800 | 35.09 | 905,322 |
| 2021-08-05 | Esposito Pamela (Chief Business Officer) | Option Ex | 25,800 | 15.50 | 399,900 |
| 2021-08-04 | Esposito Pamela (Chief Business Officer) | Sale | 4,200 | 35.00 | 147,000 |
| 2021-08-04 | Esposito Pamela (Chief Business Officer) | Option Ex | 4,200 | 15.50 | 65,100 |
| 2021-07-21 | Esposito Pamela (Chief Business Officer) | Sale | 12,538 | 33.17 | 415,885 |
| 2021-07-21 | Esposito Pamela (Chief Business Officer) | Option Ex | 12,538 | 1.01 | 12,663 |
| 2021-07-20 | Esposito Pamela (Chief Business Officer) | Sale | 4,862 | 33.05 | 160,689 |
| 2021-07-20 | Esposito Pamela (Chief Business Officer) | Option Ex | 4,862 | 1.01 | 4,910 |
| 2021-07-15 | Esposito Pamela (Chief Business Officer) | Sale | 4,600 | 33.37 | 153,502 |
| 2021-07-15 | Esposito Pamela (Chief Business Officer) | Option Ex | 4,600 | 1.01 | 4,646 |
| 2021-07-15 | Love Colin (Chief Operating Officer) | Sale | 30,000 | 32.02 | 960,600 |
| 2021-07-02 | Coffin Robert (President & Chief R&D Officer) | Sale | 7,810 | 40.04 | 312,712 |
| 2021-04-15 | Love Colin (Chief Operating Officer) | Sale | 30,000 | 30.34 | 910,050 |
| 2021-03-15 | Love Colin (Chief Operating Officer) | Sale | 30,000 | 33.32 | 999,510 |
| 2021-02-16 | Love Colin (Chief Operating Officer) | Sale | 30,000 | 36.23 | 1,086,750 |
| 2021-02-08 | Stampacchia Otello (Director) | Sale | 5,249 | 45.00 | 236,205 |
| 2021-01-26 | Rhodes Jason P (Director) | Sale | 5,558 | 46.14 | 256,446 |
| 2021-01-26 | Stampacchia Otello (Director) | Sale | 30,350 | 45.69 | 1,386,691 |
| 2021-01-22 | Coffin Robert (President & Chief R&D Officer) | Sale | 60,000 | 44.43 | 2,665,800 |
| 2021-01-22 | Stampacchia Otello (Director) | Sale | 11,359 | 45.04 | 511,609 |
| 2021-01-19 | Esposito Pamela (Chief Business Officer) | Sale | 5,727 | 42.81 | 245,172 |
| 2021-01-19 | Esposito Pamela (Chief Business Officer) | Option Ex | 5,727 | 1.01 | 5,784 |
| 2021-01-19 | Love Colin (Chief Operating Officer) | Sale | 7,857 | 42.81 | 336,397 |
| 2021-01-19 | Astley-sparke Philip (Chief Executive Officer) | Sale | 8,432 | 42.77 | 360,678 |
| 2021-01-15 | Esposito Pamela (Chief Business Officer) | Sale | 29,273 | 43.58 | 1,275,717 |
| 2021-01-15 | Esposito Pamela (Chief Business Officer) | Option Ex | 29,273 | 1.01 | 29,565 |
| 2021-01-15 | Love Colin (Chief Operating Officer) | Sale | 22,143 | 43.96 | 973,406 |
| 2021-01-15 | Astley-sparke Philip (Chief Executive Officer) | Sale | 16,568 | 43.89 | 727,219 |
| 2021-01-15 | Stampacchia Otello (Director) | Sale | 1,916 | 45.19 | 86,584 |
| 2021-01-14 | Esposito Pamela (Chief Business Officer) | Sale | 20,000 | 45.02 | 900,400 |
| 2021-01-14 | Esposito Pamela (Chief Business Officer) | Option Ex | 20,000 | 1.01 | 20,200 |
| 2021-01-14 | Franchi Jean M. (Chief Financial Officer) | Sale | 14,900 | 44.27 | 659,697 |
| 2021-01-14 | Franchi Jean M. (Chief Financial Officer) | Option Ex | 14,900 | 14.08 | 209,792 |
| 2021-01-14 | Astley-sparke Philip (Chief Executive Officer) | Sale | 25,000 | 43.82 | 1,095,425 |
| 2021-01-14 | Stampacchia Otello (Director) | Sale | 17,664 | 45.09 | 796,469 |
| 2021-01-13 | Franchi Jean M. (Chief Financial Officer) | Sale | 100 | 44.19 | 4,419 |
| 2021-01-13 | Franchi Jean M. (Chief Financial Officer) | Option Ex | 100 | 14.08 | 1,408 |
| 2020-12-23 | Esposito Pamela (Chief Business Officer) | Option Ex | 50,704 | 1.75 | 88,732 |
| 2020-12-22 | Coffin Robert (President & Chief R&D Officer) | Sale | 220,000 | 40.04 | 8,808,800 |
| 2020-12-18 | Rhodes Jason P (Director) | Sale | 4,319 | 41.95 | 181,182 |
| 2020-12-17 | Rhodes Jason P (Director) | Sale | 11,535 | 42.00 | 484,470 |
| 2020-12-16 | Rhodes Jason P (Director) | Sale | 12,675 | 42.13 | 533,997 |
| 2020-12-15 | Rhodes Jason P (Director) | Sale | 40,819 | 43.20 | 1,763,380 |
| 2020-12-14 | Franchi Jean M. (Chief Financial Officer) | Sale | 25,000 | 42.88 | 1,072,075 |
| 2020-12-14 | Franchi Jean M. (Chief Financial Officer) | Option Ex | 25,000 | 14.08 | 352,000 |
| 2020-12-14 | Rhodes Jason P (Director) | Sale | 37,659 | 43.43 | 1,635,530 |
| 2020-12-11 | Esposito Pamela (Chief Business Officer) | Option Ex | 12,590 | 3.30 | 41,547 |
| 2020-12-11 | Rhodes Jason P (Director) | Sale | 31,636 | 43.62 | 1,379,962 |
| 2020-12-10 | Rhodes Jason P (Director) | Sale | 34,391 | 43.50 | 1,496,111 |
| 2020-12-10 | Astley-sparke Philip (Chief Executive Officer) | Sale | 25,000 | 43.03 | 1,075,825 |
| 2020-12-09 | Rhodes Jason P (Director) | Sale | 41,216 | 44.16 | 1,820,180 |
| 2020-12-09 | Love Colin (Chief Operating Officer) | Sale | 30,000 | 43.92 | 1,317,720 |
| 2020-12-09 | Astley-sparke Philip (Chief Executive Officer) | Sale | 25,000 | 43.93 | 1,098,200 |
| 2020-12-08 | Rhodes Jason P (Director) | Sale | 108,256 | 46.49 | 5,033,037 |
| 2020-12-08 | Slattery Joseph P | Sale | 5,200 | 46.00 | 239,200 |
| 2020-12-08 | Slattery Joseph P | Option Ex | 5,200 | 3.30 | 17,160 |
| 2020-12-07 | Rhodes Jason P (Director) | Sale | 67,890 | 46.12 | 3,131,358 |
| 2020-12-07 | Dhingra Kapil | Sale | 40,000 | 46.12 | 1,844,680 |
| 2020-12-07 | Dhingra Kapil | Option Ex | 40,000 | 1.75 | 70,000 |
| 2020-11-16 | Love Colin (Chief Operating Officer) | Sale | 15,000 | 45.29 | 679,395 |
| 2020-10-14 | Esposito Pamela (Chief Business Officer) | Sale | 16,000 | 32.59 | 521,520 |
| 2020-10-14 | Esposito Pamela (Chief Business Officer) | Option Ex | 16,000 | 1.01 | 16,160 |
| 2020-09-15 | Love Colin (Chief Operating Officer) | Sale | 15,000 | 24.01 | 360,150 |
| 2020-08-31 | Esposito Pamela (Chief Business Officer) | Sale | 5,000 | 27.05 | 135,250 |
| 2020-08-31 | Esposito Pamela (Chief Business Officer) | Option Ex | 5,000 | 1.01 | 5,050 |
| 2020-08-17 | Love Colin (Chief Operating Officer) | Sale | 15,000 | 23.39 | 350,925 |
| 2020-07-09 | Coffin Robert (President & Chief R&D Officer) | Sale | 169,750 | 21.67 | 3,678,482 |
| 2020-02-20 | Coffin Robert (Pres & Chief Res & Dev Officer) | Sale | 24,250 | 17.04 | 413,220 |
| 2020-02-12 | Coffin Robert (Pres & Chief Res & Dev Officer) | Sale | 48,500 | 17.04 | 826,197 |
| 2019-12-20 | Esposito Pamela (Chief Business Officer) | Option Ex | 25,700 | 1.75 | 44,975 |
| 2019-11-26 | Kaufman Howard (Chief Medical Officer) | Option Ex | 58,067 | 3.30 | 191,621 |
| 2019-11-18 | Rhodes Jason P (Director) | Buy | 1,100,000 | 13.61 | 14,971,000 |
| 2019-11-18 | Stampacchia Otello | Buy | 220,000 | 13.61 | 2,994,200 |
| 2019-11-06 | Love Colin (Chief Operating Officer) | Sale | 22,500 | 17.01 | 382,725 |
| 2019-11-06 | Coffin Robert (President and CEO) | Sale | 48,500 | 17.01 | 824,985 |
| 2019-11-06 | Astley-sparke Philip (Executive Chairman) | Sale | 29,000 | 17.01 | 493,290 |
| 2019-11-04 | Love Colin (Chief Operating Officer) | Sale | 22,500 | 17.03 | 383,085 |
| 2019-11-04 | Coffin Robert (President and CEO) | Sale | 48,500 | 17.03 | 825,761 |
| 2019-11-04 | Astley-sparke Philip (Executive Chairman) | Sale | 29,000 | 17.03 | 493,754 |
| 2019-10-31 | Love Colin (Chief Operating Officer) | Sale | 11,250 | 17.00 | 191,250 |
| 2019-10-31 | Coffin Robert (President and CEO) | Sale | 24,250 | 17.00 | 412,250 |
| 2019-10-31 | Astley-sparke Philip (Executive Chairman) | Sale | 14,500 | 17.00 | 246,500 |
| 2019-09-23 | Love Colin (Chief Operating Officer) | Sale | 11,250 | 17.05 | 191,812 |
| 2019-09-23 | Coffin Robert (President and CEO) | Sale | 24,250 | 17.05 | 413,462 |
| 2019-09-23 | Astley-sparke Philip (Executive Chairman) | Sale | 14,500 | 17.05 | 247,225 |
| 2018-12-13 | Esposito Pamela (Chief Business Officer) | Option Ex | 87,000 | 1.75 | 152,250 |
| 2018-07-24 | Forbion Capital Fund Iii Cooperatief U.a. (10% Owner) | Buy | 133,333 | 15.00 | 1,999,995 |
| 2018-07-24 | Slootweg Hugo Alexander (Director) | Buy | 133,333 | 15.00 | 1,999,995 |
| 2018-07-24 | Paster Anne-mari (10% Owner) | Buy | 266,667 | 15.00 | 4,000,005 |
| 2018-07-24 | Koppel Adam (Director) | Buy | 500,000 | 15.00 | 7,500,000 |
| 2018-07-24 | Slattery Joseph P (Director) | Buy | 6,667 | 15.00 | 100,005 |
Insider trading activities including stock purchases, stock sales, and option exercises of REPL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Replimune Group, Inc. (symbol REPL, CIK number 1737953) see the Securities and Exchange Commission (SEC) website.